| #44 |
Bob Giargiari |
— |
1 |
| #44 |
Brett D. Allison |
Johnson & Johnson |
1 |
| #44 |
Glen Otero |
Wellstat Vaccines |
1 |
| #44 |
James Mork |
Oracle |
1 |
| #44 |
Andrew M. Blumenfeld |
AbbVie |
1 |
| #44 |
Paul DARUWALA |
Cidara Therapeutics |
1 |
| #44 |
James H. Flatt |
Martek Biosciences |
1 |
| #44 |
Peter M. Asbeck |
Rockwell International |
1 |
| #44 |
Norris Merritt |
Servicenow |
1 |
| #44 |
Adam Zeman |
Hunter Industries |
1 |
| #44 |
William Fenical |
University of California |
1 |
| #44 |
Steven F. Bierman |
Venetec International |
1 |
| #44 |
Alexander Winfield Thompson |
Oracle |
1 |
| #44 |
M. Lou Marsh |
— |
1 |
| #44 |
Pavel CHUBUKOV |
1859 |
1 |
| #44 |
Michael Steven Becker |
Illumina |
1 |
| #44 |
William R. Shanahan |
Arena Pharmaceuticals |
1 |
| #44 |
Stephen H. Howell |
University of California |
1 |
| #44 |
Margrith Mattmann |
Biomatrica |
1 |
| #44 |
Robert Michael McGraw |
— |
1 |
| #44 |
Alexis Dechelette |
Amgen |
1 |
| #44 |
Leonard Mulkowsky |
Carefusion 303 |
1 |
| #44 |
Derek Gerstmann |
Intel |
1 |
| #44 |
Milan Mitrovic |
Rohr |
1 |
| #44 |
Ahmet Tutuncu |
Respivant Sciences Gmbh |
1 |
| #44 |
David Windsor Rillie |
Solatube International |
1 |
| #44 |
Carol A. Becker |
US Air Force |
1 |
| #44 |
Sudeepto Kumar Roy |
Aruba Networks |
1 |
| #44 |
Ronald Swanson |
Johnson & Johnson |
1 |
| #44 |
James C. Paulson |
Cytel |
1 |
| #44 |
Mark D. Erion |
Metabasis Therapeutics |
1 |
| #44 |
Timothy Knowles |
Kulr Technology |
1 |
| #44 |
Ronald H. Rosenfield |
Hamilton Sundstrand |
1 |
| #44 |
Devon CAYER |
1859 |
1 |
| #44 |
Don W. Cleveland |
Ionis Pharmaceuticals |
1 |
| #44 |
William Gerhart |
Respivant Sciences Gmbh |
1 |
| #44 |
Richard M. Batch |
Carefusion 303 |
1 |
| #44 |
Stephen B. Howell |
Research Development Foundation |
1 |
| #44 |
Christian Cole |
University of California |
1 |
| #44 |
Richard L. Austin |
— |
1 |
| #44 |
Paul William Finnegan |
— |
1 |
| #44 |
Lisa Lynn Caralli |
— |
1 |
| #44 |
Christopher N. Quinn |
Intuit |
1 |
| #44 |
Stephen Andrew Thomson |
Vertex Pharmaceuticals Incorporated |
1 |
| #44 |
Daniel I. Bodenheimer |
— |
1 |